Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Inherited Metabolic Disease
Literature
Aeby A, Prigogine C, Vilain C et al (2016) RFT1-congenital disorder of glycosylation (CDG) syndrome: a cause of early-onset severe epilepsy. Epileptic Disord 18:92–96PubMed
Al Teneiji A, Bruun TU, Sidky S et al (2017) Phenotypic and genotypic spectrum of congenital disorders of glycosylation type 1 and type II. Mol Genet Metab 120:235–242CrossRefPubMed
Arslan S, Işik AU, Imamoğlu M et al (2013) Universal newborn hearing screening; automated transient evoked otoacoustic emissions. B-ENT 9:122–131PubMed
Barba C, Darra F, Cusmai R et al (2016) Congenital disorders of glycosylation presenting as epileptic encephalopathy with migrating partial seizures in infancy. Dev Med Child Neurol 58:1085–1091CrossRefPubMed
Barone R, Carrozzi M, Parini R et al (2015) A nationwide survey of PMM2-CDG in Italy: high frequency of a mild neurological variant associated with the L32R mutation. J Neurol 262:154–164CrossRefPubMed
Enns GM, Steiner RD, Buist N et al (2002) Clinical and molecular features of congenital disorder of glycosylation in patients with type 1 sialotransferrin pattern and diverse ethnic origins. J Pediatr 141:695–700CrossRefPubMed
Feraco P, Mirabelli-Badenier M, Severino M et al (2012) The shrunken, bright cerebellum: a characteristic MRI finding in congenital disorders of glycosylation type Ia. Am J Neuroradiol 33:2062–2067CrossRefPubMed
García Silva MT, de Castro J, Stibler H et al (1996) Prenatal hypertrophic cardiomyopathy and pericardial effusion in carbohydrate-deficient glycoprotein syndrome. J Inherit Metab Dis 19:257–259CrossRefPubMed
Gehrmann J, Sohlbach K, Linnebank M et al (2003) Cardiomyopathy in congenital disorders of glycosylation. Cardiol Young 13:345–351PubMed
Horslen SP, Clayton PT, Harding BN, Hall NA, Keir G, Winchester B (1991) Olivopontocerebellar atrophy of neonatal onset and disialotransferrin developmental deficiency syndrome. Arch Dis Child 66:1027–1032CrossRefPubMedPubMedCentral
Hutchesson ACJ, Gray RGF, Spencer DA, Keir G (1995) Carbohydrate deficient glycoprotein syndrome; multiple abnormalities and diagnostic delay. Arch Dis Child 72:445–446CrossRefPubMedPubMedCentral
Imtiaz F, Worthington V, Champion M et al (2000) Genotypes and phenotypes of patients in the UK with carbohydrate-deficient glycoprotein syndrome type 1. J Inherit Metab 23:162–174CrossRef
Jaeken J, Vleugels W, Régal L et al (2009) RFT1-CDG: deafness as a novel feature of congenital disorders of glycosylation. J Inherit Metab Dis 32(Suppl 1):S335–S338CrossRefPubMed
Kjaergaard S, Schwartz M, Skovby F (2001) Congenital disorder of glycosylation type Ia (CDG-Ia): phenotypic spectrum of the R141H/F119L genotype. Arch Dis Child 85:236–239CrossRefPubMedPubMedCentral
Messenger WB, Yang P, Pennes ME (2014) Ophthalmic findings in an infant with phosphomannomutase deficiency. Doc Ophthalmol 182:149–153CrossRef
Ondruskova N, Vesela K, Hansikova H et al (2012) RFT1-CDG in adult siblings with novel mutations. Mol Genet Metab 107:760–762CrossRefPubMed
Pascolini D, Smith A (2009) Hearing impairment in 2008: a compilation of available epidemiological studies. Int J Audiol 48:473–485CrossRefPubMed
Pérez-Cerdá C, Girós ML, Serrano M et al (2017) A population-based study oncongenital disorders of protein N- and combined with O-glycosylation experiencein clinical and genetic diagnosis. J Pediatr 183:170–177CrossRefPubMed
Régal L, van Hasselt PM, Foulquier F et al (2015) ALG11-CDG: three novel mutations and further characterization of the phenotype. Mol Genet Metab Rep 2:16–19CrossRefPubMed
Rind N, Schmeiser V, Thiel C et al (2010) A severe human metabolic disease caused by deficiency of the endoplasmic mannosyltransferase hALG11 leads to congenital disorder of glycosylation-Ip. Hum Mol Genet 19:1413–1424CrossRefPubMed
Szlago M, Massari M, Cayssials A, Caceres L, Matthijs G, Jaeken J (2006) Congenital disorders of glycosylation type I a (CDG Ia) in argentine: clinical, biochemical and molecular findings in two patients. J Inherit Metab Dis 29(Suppl 1):161
Thiel C, Rind N, Popovici GF et al (2012) Improved diagnostics leads to identification of three new patients with congenital disorder of glycosylation-Ip. Hum Mutat 33:485–487CrossRefPubMed
Ulusoy S, Ugras H, Cingi C et al (2014) The results of national newborn hearing screening (NNHS) data of 11,575 newborns from west part of Turkey. Eur Rev Med Pharmacol Sci 18:2995–3003PubMed
van de Kamp JM, Lefeber DJ, Ruijter GJG et al (2007) Congenital disorder of glycosylation type Ia presenting with hydrops fetalis. J Med Genet 44:277–280CrossRefPubMed
Veneselli E, Biancheri R, Di Rocco M, Tortorelli S (1998) Neurophysiological findings in a case of carbohydrate-deficient glycoprotein (CDG) syndrome type I with phosphomannomutase deficiency. Eur J Paediatr Neurol 2:239–244CrossRefPubMed
Metadata
Title
PMM2-CDG and sensorineural hearing loss
Authors
Çiğdem Seher Kasapkara
Zeren Barış
Mustafa Kılıç
Deniz Yüksel
Lies Keldermans
Gert Matthijs
Jaak Jaeken
Publication date
01-09-2017
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 5/2017
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-017-0073-z

Other articles of this Issue 5/2017

Journal of Inherited Metabolic Disease 5/2017 Go to the issue

Images in Metabolic Medicine

Carnitine palmitoyltransferase 1A deficiency: abnormal muscle biopsy findings in a child presenting with Reye’s syndrome

Editorial

Rescuing Canavan disease: engineering the wrong cell at the right time

Review

Linking mitochondrial dysfunction to neurodegeneration in lysosomal storage diseases

Original Article

Developmental window of sensorineural deafness in biotinidase-deficient mice

Original Article

A novel conditional Sgsh knockout mouse model recapitulates phenotypic and neuropathic deficits of Sanfilippo syndrome

Original Article

Risk factors for poor bone health in primary mitochondrial disease
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits